Michael Brian Bell net worth and biography

Michael Bell Biography and Net Worth

CFO of Guardant Health

Michael Bell is the Chief Financial Officer at Guardant Health, where he oversees the company’s financial activities. Bell has more than 30 years experience, and prior to Guardant he led the global financial operations of leading clinical diagnostic companies, including serving as the CFO of CareDx, Novartis Diagnostics and Singulex. He also worked in public accounting and consulting at Deloitte and Ernst & Young. Bell holds a Bachelor of Science degree in Mathematics with Computing from the University of Leicester in the United Kingdom, and is a Fellow of the Institute of Chartered Accountants in England and Wales.

What is Michael Brian Bell's net worth?: The estimated net worth of Michael Brian Bell is at least $3.02 million as of December 5th, 2025. Bell owns 28,052 shares of Guardant Health stock worth more than $3,017,554 as of January 12th. This net worth estimate does not reflect any other assets that Bell may own. Additionally, Bell receives an annual salary of $630,990.00 as CFO at Guardant Health. Learn More about Michael Brian Bell's net worth.
How old is Michael Brian Bell?: Bell is currently 55 years old. There are 7 older executives and no younger executives at Guardant Health. The oldest executive at Guardant Health is Mr. Kumud Kalia, Chief Information Officer, who is 58 years old. Learn More on Michael Brian Bell's age.
What is Michael Brian Bell's salary?: As the CFO of Guardant Health, Inc., Bell earns $630,990.00 per year. The highest earning executive at Guardant Health is Dr. Craig Eagle M.D., Chief Medical Officer, who commands a salary of $649,130.00 per year. Learn More on Michael Brian Bell's salary.
How do I contact Michael Brian Bell?: The corporate mailing address for Bell and other Guardant Health executives is 505 PENOBSCOT DR., REDWOOD CITY CA, 94063. Guardant Health can also be reached via phone at (855) 698-8887 and via email at [email protected]. Learn More on Michael Brian Bell's contact information.
Has Michael Brian Bell been buying or selling shares of Guardant Health?: Michael Brian Bell has not been actively trading shares of Guardant Health during the last quarter. Most recently, Michael Brian Bell sold 80,362 shares of the business's stock in a transaction on Friday, December 5th. The shares were sold at an average price of $103.14, for a transaction totalling $8,288,536.68. Following the completion of the sale, the chief financial officer now directly owns 28,052 shares of the company's stock, valued at $2,893,283.28. Learn More on Michael Brian Bell's trading history.
Who are Guardant Health's active insiders?: Guardant Health's insider roster includes Michael Bell (CFO), Derek Bertocci (CFO), Darya Chudova (CTO), Ian Clark (Director), Helmy Eltoukhy (CEO), Chris Freeman (Chief Commercial Officer, Oncology), Medina Hidalgo (Director), Meghan Joyce (Director), Kumud Kalia (Insider), Samir Kaul (Director), Stanley Meresman (Director), Amelia Merrill (SVP), Terilyn Monroe (Insider), Myrtle Potter (Director), John Saia (Insider), Amirali Talasaz (COO), and Musa Tariq (Director). Learn More on Guardant Health's active insiders.
Are insiders buying or selling shares of Guardant Health?: During the last year, insiders at the sold shares 42 times. They sold a total of 1,082,007 shares worth more than $80,709,932.39. The most recent insider tranaction occured on January, 7th when insider Terilyn J Monroe sold 10,031 shares worth more than $1,124,274.48. Insiders at Guardant Health own 6.1% of the company. Learn More about insider trades at Guardant Health.
Information on this page was last updated on 1/7/2026.

Michael Brian Bell Insider Trading History at Guardant Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
12/5/2025	Sell	80,362	$103.14	$8,288,536.68	28,052

Michael Brian Bell Buying and Selling Activity at Guardant Health

Guardant Health Company Overview

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.

Today's Range

Now: $107.57

$103.80

$113.91

50 Day Range

MA: $102.14

$94.13

$112.33

2 Week Range

Now: $107.57

$34.88

$113.91

Volume

2,356,343 shs

Average Volume

2,524,306 shs

Market Capitalization

$13.56 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58

Michael Bell Biography and Net Worth

What is Michael Brian Bell's net worth?

How old is Michael Brian Bell?

What is Michael Brian Bell's salary?

How do I contact Michael Brian Bell?

Has Michael Brian Bell been buying or selling shares of Guardant Health?

Who are Guardant Health's active insiders?

Are insiders buying or selling shares of Guardant Health?